Shanghai RAAS Blood Products Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Shanghai RAAS Blood Products Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase II Exploratory Study of SR604 Injection Evaluating the Safety and Efficacy in the Treatment of Congenital Coagulation Factor VII Deficiency (NCT07711158) | Shanghai RAAS Blood Products Co., Ltd. | 2026-07-01 |
| A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand Disease (NCT07640893) | Shanghai RAAS Blood Products Co., Ltd. | 2025-11-26 |
| An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency (NCT07644832) | Shanghai RAAS Blood Products Co., Ltd. | 2024-05-31 |
Track Shanghai RAAS Blood Products Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.